Supporting the Next Wave of Therapeutic Innovation
Featured Therapeutic Markets (ADC & GLP-1)
ILC Dover delivers advanced containment and single‑use solutions for today’s most innovative therapeutic markets, including GLP‑1 therapies, antibody–drug conjugates (ADCs), cell & gene therapy, biologics, and small molecule manufacturing. Our solutions are engineered to address high‑potency handling, contamination control, and regulatory compliance—supporting safe, efficient, and scalable operations from development through commercialization.
With decades of expertise and cutting‑edge technology, ILC Dover helps manufacturers accelerate time‑to‑market, protect personnel and products, and maintain uncompromising quality.
ILC Dover — your partner in advancing modern therapeutic manufacturing.
.png?format=pjpeg&width=1600&quality=75&auto=webp)









